Latest Breaking News On - Prnewswire maxcyte inc - Page 2 : comparemela.com

MaxCyte Announces Pricing of Upsized Offering and Approval to List on the Nasdaq Global Select Market This announcement contains inside information News provided by Share this article Share this article GAITHERSBURG, Md., July 29, 2021 /PRNewswire/ MaxCyte, Inc., (LSE: MXCT, MXCN), a leading provider of cell-engineering platform technologies, today announced the pricing of its upsized offering of 13,500,000 shares of common stock at an initial offering price of US$13.00 per share (the Offering ). Highlights Anticipated gross proceeds of approximately US$175,500,000 (or US$201,825,000 if the underwriters exercise their option to purchase additional shares of common stock in full), before deducting underwriting discounts and commissions and estimated offering expenses payable by MaxCyte

New yorkUnited statesEdgewoodGaithersburgMarylandChicagoIllinoisLondonCity ofUnited kingdomRiverside plazaSan franciscoCaliforniaPanmure gordonWilliam blairPrnewswire maxcyte inc